PULMOBIOMED is addressing the failings of current lung tests, which are expensive, infrequent, and invasive. Their so-called "clinically proven" solution claims to offer non-invasive liquid samples from deep within the lung, promising affordable tests for lung diseases. They assert that their product can empower clinicians to diagnose and treat conditions like lung cancer and infections, even though there's limited evidence to support these claims. With a few customers in the USA and Australia, and vague partnerships in the EU, PULMOBIOMED hopes to disrupt the asthma diagnostics market by introducing what they call a comprehensive diagnostic test for asthma, despite the skepticism around their capabilities.
days to go:
Extended
investment:
£295,000
Plerith works with high growth start-ups and scaling companies to plan for and deliver growth. The company asserts that it helps companies promote their business to potential funders, through its network of angel and venture capital investors depending on the stage and sector of the said business. Plerith is partnering with Newable and Bristol Private Equity Club to deliver the fund in the South West London (SWL) area and identify and invest in the most exciting high growth companies in the region. Plerith argues that its deep knowledge of fundraising, sales, strategy, finance and technology would help SWL businesses flourish. Plerith aims to provide investors access to the highest quality local companies in the SWL region.
days to go:
Stretch
investment:
Withheld
Carocell Bio is innovating by developing patented anti-inflammatory peptides delivered via nanoparticles to address severe inflammatory conditions such as atopic dermatitis. Their primary peptide, JEL0305, not only halts inflammation but also prevents its initiation, as evidenced by its effectiveness in reducing inflammation in human AD biopsies and burn tissue. With AD impacting a substantial population and costing $21 billion yearly for unsafe treatments, Carocell Bio's safer peptide remedy has the potential to avert AD recurrence. Additionally, their pioneering approach to skin-related inflammation involves topical peptide products that target mitogen-activated protein kinase (MAPK), a crucial element in inflammation. This breakthrough offers promise for managing and forestalling AD and mitigating skin aging.
days to go:
Extended
investment:
Withheld
Optimise BP, the debut product by Optimise Health, introduces an innovative digital solution that offers secure and efficient semi-automated blood pressure management within primary care, focusing on hypertension. This advancement is projected to lead to substantial appointment savings in the range of millions.
days to go:
TBC
investment:
£127,001
Birchwood Marine is one of the best British brands in the boat manufacturing business. It has a dedicated team of loyal dealers and has over 5000 boats to its credit. The company has an M.O.U Agreement with a reputed and established manufacturer in Argentina. It is also planning to re-launch Birchwood by using a joint-venture manufacturing association and produce a range of Sport Express and Flybridge models (from 34ft to 74ft), which will be sold in the US, EU, the UK, the UAE and China market. With the proceeds, the company will purchase two more boats for the forthcoming Southampton In-Water Boat Show, 2019 and the Dusseldorf Indoor Show, 2020.
days to go:
Expired
investment:
£82,140
The Clubhouse is a professional space that offers an alternative meeting place for businesses of all sizes. Also, it offers complimentary WiFi, refreshments, tea, Nespresso coffee and a dedicated team to help out.
days to go:
Expired
investment:
£950,915
Milbotix, a healthtech start-up, supported by the Alzheimer's Society and the UK Dementia Research Institute, is driven by its innovative product SmartSocks™. This wearable technology aims to assist individuals with dementia facing communication challenges and their caregivers. Globally, the number of people with dementia is increasing significantly, reaching 78 million by 2030 and 139 million by 2050. Half of those diagnosed with dementia encounter challenging behavioral symptoms due to distress. Early distress management not only enhances well-being but also helps prevent escalating behavioral issues. SmartSocks™ utilize sensors and artificial intelligence to notify dementia caregivers about early signs of pain and anxiety in their patients.
days to go:
Expired
investment:
£220,780
Peliwica Insurance is set up to disrupt the current rural, equine, and agriculture insurance broker markets. It is a new Insuretech business that was launched in 2018. In the same year, the company gained its first FCA Approval and the Lloyds CoverHolder status that held the key enablers to launch this business. Peliwica Insurance is trading with 10 Brokers with a £100m premium opportunity. With its upcoming mobile application and devised white-labelled D2C platforms, the company will be able to allow brokers to access new product markets and customers more effectively.
days to go:
Expired
investment:
£75,980
Verado is a data-driven and scalable proprietary platform that aims to eradicate counterfeits within the watch & jewelry industry. It enables private sellers to sell their luxury watches autonomously online. Verado analyzes thousands of similar items across the internet and gives the fairest price for both buyers and sellers. By adding verification, authentication and financial escrow, Verado is solving a basic problem associated with buying and selling fine jewelry. In a market with zero transparency, Verado is able to provide a community for collectors, sellers, and buyers. The platform has the security and personality of old school selling with the reach and speed of an online platform. The company has achieved €400,000+ sales and 10,000 cellular listings onto the platform. Verado has been featured in many publications like watchuseek, Forbes, and Buzzfeed. With the proceeds, the company is planning to build awareness and build upon its growing community.
days to go:
Expired
investment:
£37,270
Zenos Cars are a designer, manufacturer and retailer of sports cars. Zenos cars are designed to be thrilling, lightweight, high performance and affordable. Zenos have a management team with plenty of experience having previously worked at Caterham and Lotus Cars.
days to go:
Expired
investment:
£169,200
